Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Canadian_101on Sep 09, 2020 9:33am

220 Views

Post# 31525885

RE:RE:RE:RE:Dr. John Wallace

I for one can tell you Bob is right a lot more than wrong....he has helped me make so much money on a yearly basis its not funny, I can list at least 5 stocks I have had doubles or triples on from his top picks or analysis , anyone to call him " a fool" speaks volumes about that persons IQ level.

I am sure there are many investors who would agree with my expert opinion!!!!

Good luck to all

Inthepez wrote: I agree Mark. But I wouldn’t too much weight to to what mcwhirter has to say. The fool didn’t even know about the liver enzymes, during th dockside chat on biopub. He asked why didn’t ATE disclose, that information during the Q&A portion.

Marky1 wrote:
Which discussion are you referring to?? I've been in this company since August 2019 when Bob McWhirter chose it a top pick.

My shares are stored away in my vault of hopes and wishes..

everyone out there...We have a winner, we have the greatest drug invention since Acetaminophen ( not an NSAID ) The market cap should, and will be, as said in the BioPub, 600M$ USD which works out to be $2 a share CDN....
Patience is a virtue and a necessary state of mind here..